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Background: Not performing a day (D) 7 patch test reading might result in positive
patch test reactions being missed.
Objectives: To investigate the added value of the D7 patch test reading for individual
allergens, and to identify patient characteristics and allergen groups associated with
new positive D7 reactions.
Methods: Data from patients patch tested between 2008 and 2018 with the
extended European baseline series were analysed. Patch test readings were per-
formed on D3 and D7. Positive reactions were categorized into positive on D3 or
new positive on D7.
Results: A total of 3292 patients were consecutively patch tested with at least
43 allergens of the TRUE Test panels 1 and 2 supplemented with investigator-loaded
allergens. In total, 447 (13.6%) patients showed new positive D7 reactions. In
univariable regression analysis, age between 18 and 30 years showed a negative
association with new positive D7 reactions. Significantly more D7 positive reactions
were seen for topicals (odds ratio [OR] 2.60, 95% confidence interval [CI]: 1.92-3.51)
and corticosteroids (OR 1.87, 95%CI: 1.09-3.21). No associations were found
between sex, atopic dermatitis and occupational dermatitis and a new positive D7
reaction.
Conclusion: A D7 reading to identify new positive patch test reactions is of added
value, especially for topicals and corticosteroids.
K E YWORD S
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1 | INTRODUCTION
According to the European Society of Contact Dermatitis (ESCD)
guideline for diagnostic patch testing, it is recommended to perform
at least two readings, on day (D) 2, D3, or D4, and around D7.1 Most
centres perform patch test readings on D2 to D4. A late patch test
reading on D7 in addition to the D3 or D4 reading can identify new
positive patch test reactions, ranging from 3% up to 34% in previous
studies, which were found to be negative, doubtful or irritant on pre-
ceding readings.2-9 Multiple studies have reported the importance of
an additional late patch test reading, especially for suspected contact
allergies to metals, topicals, and corticosteroids. However, the
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allergens that have shown new positive reactions at an additional late
patch test reading vary in the literature.7,10,11 It is unknown whether
there are associated factors, for example, patient characteristics, that
may enhance the tendency to develop new positive reactions at a D7
reading. Only one study evaluated sex and age as possible associated
factors, and found a significantly higher rate of new positive D7 reac-
tions in women than in men and in patients aged >40 years.7 The
objectives of the current study were to evaluate the added value of
the D7 patch test reading for individual allergens and allergen groups,
and to identify factors associated with new positive D7 reactions.
2 | METHODS
2.1 | Study design and patch testing
We performed a retrospective data analysis on patch test data collected
between January 2008 and July 2018 for consecutively patch tested
patients who were routinely tested with our extended European base-
line series. TRUE Test panels 1 and 2 (SmartPractice Europe, Reinbek,
Germany) supplemented with additional investigator-loaded allergens
(SmartPractice Europe, and Chemotechnique Diagnostics, Vellinge,
Sweden) tested in Van der Bend square chambers (Van der Bend,
Brielle, The Netherlands) were applied on the back for 48 hours under
occlusion. Patch test readings were performed on D3 and D7. The read-
ings were performed by experienced dermatologists according to the
ESCD guideline.1 Weak (+), strong (++) and extreme (+++) reactions
were classified as positive reactions. Reactions reported as irritant,
doubtful (?+) or follicular were counted as negative reactions in addition
to the negative results. In addition, patch test results reported as irritant,
doubtful or follicular at the D3 reading that became positive on D7
were evaluated separately. Reactions were evaluated as irritant if mar-
gins were sharply demarcated and the surface of the test area showed
a silk paper structure or a shiny skin. Reactions were considered to be
doubtful if erythema and/or infiltration did not cover the whole test
area.12
2.2 | Data analysis
Positive reactions were categorized into positive on D3 or new posi-
tive on D7 (labelled as negative on D3). For patients who had been
tested more than once, only the most recent patch test result was
evaluated. To evaluate patient characteristics, three groups of patients
were defined: patients with only D3 positive reactions and no new
positive D7 reactions; patients with only new D7 positive reactions
corresponding to D3 negative reactions; and patients with both D3
positive reactions and new D7 positive reactions. The patient charac-
teristics that were analysed were age, sex, atopic dermatitis in the
patient’s lifetime, and occupational dermatitis. Age was categorized
into the following groups: <18, 19 to 30, 31 to 45, 46 to 60, and
≥61 years. To analyse the influence of type of allergen, allergens were
grouped on the basis of chemical structure, cross-reactivity, and co-
sensitization, resulting in seven groups: metals, preservatives, fra-
grances, rubbers, dyes, topical medicaments ("topicals"), and
corticosteroids (Table 1).13,14 A positive reaction to at least one of the
allergens in the group was counted as an overall positive group
reaction.
2.3 | Statistics
Descriptive data are presented in tables as numbers with percentages
and 95% confidence intervals (CIs). Prevalences are presented as both
crude and age-standardized estimates with accompanying 95%CIs.
The European standard population of 2013 was used as the reference
for age and sex standardization.15 Univariable logistic regression was
performed to analyse the association between patient characteristics
and allergen groups on new positive D7 reactions, and these were
expressed as odds ratio (ORs) with 95%CIs. Statistical analyses were
performed with SPSS v.23 (IBM, Armonk, New York) and Excel 2013
(Microsoft, Redmond, Washington).
3 | RESULTS
3.1 | New D7 positive patch test reactions
A total of 3292 patients (67.0% female, 33.0% male, mean age 42.7
± 16.9 years) were consecutively patch tested with at least 43 aller-
gens of the TRUE Test panels 1 and 2 supplemented with
investigator-loaded allergens. The sociodemographic characteristics of
the total patch tested group and the subgroup of patients with at least
TABLE 1 Overview of the composition of each allergen group
used for univariable regression analysis
Allergen group Composition
Metals Nickel sulfate, potassium dichromate, cobalt
chloride
Preservatives Paraben mix, MCI/MI, quaternium-15,
formaldehyde, thiomersal, MI, MDBGN,
2-bromo-2-nitropropane-1,3-diol, diazolidinyl
urea, imidiazolidinyl urea, 1,2-benzisothiazolin-
3-one
Fragrances FM I, Myroxylon pereirae resin (balsam of Peru),
FM II, HICC
Rubber additives Carba mix, black rubber mix, MBT, mercapto mix,
thiuram mix
Dyes p-Phenylenediamine, textile dye mix, Disperse
Blue 106, Disperse Blue 124, toluene-
2,5-diamine
Topicals Neomycin sulfate, lanolin alcohols, caine mix,
quinoline mix, sesquiterpene lactone mix,
parthenolide, Amerchol L 101
Corticosteroids Budesonide, tixocortol pivalate, hydrocortisone-
17-butyrate
Abbreviations: FM I, fragrance mix I; FM II, fragrance mix II; HICC,
hydroxyisohexyl 3-cyclohexene carboxaldehyde (Lyral); MBT,
mercaptobenzothiazole; MCI, methylchloroisothiazolinone; MDBGN,
methyldibromo glutaronitrile; MI, methylisothiazolinone.
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one positive reaction are shown in Table 2. A total of 1653 patients
(50.2%) had at least one positive reaction on D3 and/or D7. Of the
total 3292 patch tested patients, 189 (5.7%) showed only new posi-
tive D7 reactions (ie, read as negative, doubtful or irritant on D3) and
another 258 (7.8%) patients showed positive D3 reactions with addi-
tional new positive D7 reactions. Thus, in total, 447 (13.5%) of the
patch tested patients had new positive D7 patch test reactions. Both
crude and age-standardized and sex-standardized prevalences of the
total number of positive reactions on D3 and D7 are shown together
with 95%CIs in Table 3. The allergens with the highest proportions of
new positive D7 reactions (new positive D7 reactions/total positive
reactions) in order of frequency were neomycin sulfate (81.5%, 22/27
patients), 2-bromo-2-nitropropane-1,3-diol (50%, 11/22 patients),
budesonide (42.3%, 11/26 patients) and diazolidinyl urea (41.4%,
12/29 patients). For groups of allergens, the proportions of new posi-
tive D7 reactions were, in order of decreasing frequency, most fre-
quent for topicals (33.3%, 72/216 patients), corticosteroids (28.4%,
19/67 patients), dyes (20.2%, 53/263 patients), fragrances (16.6%,
95/572), metals (16.3%, 147/904), preservatives (15.1%, 113/749),
and rubber additives (7.6%, 23/304).
3.2 | Regression analysis
A univariable logistic regression analysis was performed to investigate
patient characteristics and allergen groups possibly associated with
the occurrence of new positive D7 reactions. The results are shown in
Table 4. For age, a significant negative association was found in the
age group 18 to 30 years as compared with the age group >61 years
(OR 0.58, 95% CI: 0.36-0.93). No significant associations were found
for sex, atopic dermatitis in the patient’s lifetime and occupational
dermatitis and a new positive D7 reaction. Significant associations
were found for the allergen groups of topicals (OR 2.60, 95% CI
1.92-3.51) and corticosteroids (OR 1.87, 95% CI 1.09-3.21) and a new
positive D7 reaction. Rubbers showed the lowest prevalence (7.6%)
of new positive D7 reactions, and were significantly negatively associ-
ated with new positive D7 reactions (OR = 0.37, 95% CI: 0.24-0.57).
Table S1 shows the prevalence of new positive D7 reactions in each
age group for each allergen group.
3.3 | Reaction strength
The reaction strength of the new positive D7 reactions and patch test
results of the D3 reading are shown in Table 3. Of the 595 new posi-
tive D7 reactions in 189 patients, 548 (92.1%) were weak positive (+)
and 46 (7.7%) were strong positive (++), especially to nickel sulfate,
parthenolide, methylchloroisothiazolinone/methylisothiazolinone,
colophonium, and epoxy resin. Only one extreme positive (+++) reac-
tion was seen, namely, to epoxy resin. Of all new positive D7 reac-
tions, 164 of 595 (27.6%) were regarded as doubtful and 4 of
595 (0.7%) were regarded as irritant at the D3 reading. Besides irritant
and/or doubtful reactions, follicular reactions were seen to nickel sul-
fate (18 of 104 positive D7 reactions), cobalt chloride (2 of 25 positive
D7 reactions, and ethylenediamine dihydrochloride (1 of 3 positive
D7 reactions).
4 | DISCUSSION
The present analysis provided estimates of the prevalence of new
positive D7 patch test reactions in patients consecutively patch tested
TABLE 2 Sociodemographic characteristics of the patch tested population
Total tested (N = 3292) Reacted positively on D3 and/or D7 (N = 1653)
n % 95% CI n % 95% CI
Sex
Male 1087 33.0 31.4-34.6 453 27.4 25.3-29.6
Female 2205 67.0 65.4-68.6 1200 72.6 70.4-74.7
Age (y)
<18 112 3.4 2.8-4.0 42 2.5 1.8-3.3
18-30 918 27.9 26.4-29.4 384 23.2 21.2-25.3
31-45 787 23.9 22.4-25.4 425 25.7 23.6-27.8
46-60 912 27.7 26.2-29.2 525 31.8 29.5-34.0
≥61 563 17.1 15.8-18.4 277 16.8 15.0-18.6
Atopic dermatitis (lifetime prevalence)
Yes 1409 42.8 41.1-44.5 701 42.4 40.0-44.8
No 1883 57.2 55.5-58.9 952 57.6 55.2-60.0
Occupational dermatitis
Yes 715 21.7 20.3-23.1 388 23.5 21.4-25.5
No 2577 78.3 76.9-79.7 1265 76.5 74.5-78.6
CI, confidence interval.
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with the extended European baseline series and evaluated possible
associated factors. Contact allergies would have been missed in
13.5% of the patch tested patients without a D7 reading.
In the current study, the prevalence of new positive D7 reactions
was significantly associated with the allergen groups topicals and cor-
ticosteroids. In multiple studies addressing the added value of a late
patch test reading, neomycin sulfate has been the most frequently
reported allergen associated with new positive reactions at a late
reading.2,7,10,16 This is in agreement with our findings, in which neo-
mycin sulfate was also the allergen with the highest proportion
(81.5%) of new positive D7 reactions. A review by Macdonald et al on
the characteristics of neomycin sulfate reported slow local absorption
through the skin and slow local immunological reactivity. Furthermore,
the possibility of a reservoir of neomycin being retained in the stratum
corneum for a long time could be a factor contributing to the high
share of new positive reactions at a late patch test reading.17
Although neomycin sulfate showed the highest proportion (new posi-
tive D7 reactions/total positive reactions), the total prevalence of
new positive D7 reactions in all patch tested patients was only 0.7%
(22/3209).
There have been conflicting results of studies on corticosteroids
and the association with new positive D7 reactions. In our patients,
corticosteroids were significantly associated with new positive D7
reactions, and gave a proportion of 28.4% new positive D7 reactions
for all positively tested patients. A recent study by Chaudry et al
reported that readings after D5 provided limited information, as no
new reactions were seen to 0.01% budesonide, 1% clobetasol-17-pro-
pionate, 1% hydrocortisone-17-butyrate alcohol and 1% triamcino-
lone acetonide in 298 evaluated patients.10 It is interesting to note
that budesonide was tested at a higher concentration of 0.1% in our
baseline series. Davis et al evaluated 135 patients, and only two
patients showed positive patch test reactions to corticosteroids, on
D7 and D9. In their experience, the extended reading was of limited
value.18 A study by Higgens et al presented 203 patients; no new pos-
itive reactions were observed to corticosteroids.6 Conversely, Madsen
et al found a second reading on D6/D7 to be important for
hydrocortisone-17-butyrate and budesonide.7 Because of the anti-
inflammatory effect, false-negative patch test reactions at
early readings can be expected when corticosteroids are tested at
high concentrations.19,20 Furthermore, corticosteroids induce local
vasoconstriction with initial blanching and/or later vasodilatation. A
possible positive patch test reaction could be confused with weak ery-
thema resulting from vasodilatation. A further confounding issue is
the “edge effect” phenomenon. In a classic positive patch test reac-
tion, induration, erythema and infiltration cover the whole area. The
edge effect is the manifestation of the skin reaction at the outer edge
of the patch test site. It is believed that the anti-inflammatory effect
of high concentrations predominates in the centre, and low concen-
trations prevail at the periphery. An earlier study investigating the
edge effect in patch testing with budesonide found that these reac-
tions become more clearly positive at later readings, further
supporting the need for a late reading.21 The differences in patch test
concentrations between our study and recent studies, in addition to
the challenges of patch test reading resulting from the anti-
inflammatory nature of corticosteroids, might explain the conflicting
results in the literature.
In our cohort, a total of 607 patients reacted positively to nickel
sulfate, and 104 (17.1%) of these reactions were new positive D7
reactions. It is interesting to note that 18 of these 104 new positive
D7 reactions were labelled as follicular reactions at the corresponding
D3 reading. Furthermore, nickel sulfate was the allergen with the
highest number (n = 22) of doubtful or irritant reactions on D3 that
became strong positive (++) by D7. A study by Thomas et al showed
nickel sulfate to be the allergen with the second highest number of
new positive D6 reactions. Of the 32 positive reactions, 11 (34.4%)
appeared on D6.11 Ahlgren et al found a significantly higher frequency
of new positive D7 reactions to metals, especially to mercury, nickel,
gold, and cobalt.5 Chaudry et al reported late readings to be useful for
TABLE 4 Logistic regression analysis with new positive patch test
reactions on day 7 as outcome
Patients (N = 189)
Factorsa n (%) OR 95% CI
Sex Male 56 (29.6) 1.00
(ref.)
Female 133 (70.4) 1.13 0.81-1.58
Age (y) <18 6 (3.2) 0.96 0.38-2.42
18-30* 35 (18.5) 0.58 0.36-0.93
31-45 48 (25.4) 0.73 0.47-1.15
46-60 59 (31.2) 0.73 0.48-1.12
≥61 41 (21.7) (ref.)
Atopic dermatitis in
lifetime
No 111 (58.7) 1.00
(ref.)
Yes 78 (41.3) 1.05 0.78-1.43
Occupational
dermatitis
No 153 (81.0) 1.0
(ref.)
Yes 36 (19.0) 1.35 0.92-1.97
Allergen groupsb Allergens (n = 522)
Metals (other = ref.) Metals 147 (28.2) 0.94 0.76-1.16
Preservatives
(other = ref.)
Preservatives 113 (21.6) 0.82 0.66-1.03
Fragrances
(other = ref.)
Fragrances 95 (18.2) 0.99 0.78-1.26
Rubbers
(other = ref.)
Rubbers** 23 (4.4) 0.37 0.24-0.57
Dyes (other = ref.) Dyes 53 (10.2) 1.28 0.93-1.76
Topicals
(other = ref.)
Topicals** 72 (13.8) 2.60 1.92-3.51
Corticosteroids
(other = ref.)
Corticosteroids*** 19 (3.6) 1.87 1.09-3.21
CI, confidence interval; OR, odds ratio.
aUnivariable.
bUnivariable regression analysis controlled for age and sex.
*P = 0.025; **P < 0.001; ***P = 0.024.
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metals, especially for gold sodium thiosulfate, which showed the
highest prevalence of new positive reactions after D5.10 In our regres-
sion analysis, the group metals was not significantly associated with
new positive D7 reactions as compared with other groups of aller-
gens. However, our metal group consisted only of nickel sulfate,
potassium dichromate and cobalt chloride from the European baseline
series.
In the current analysis, the rubbers group was the only allergen
group that was significantly less associated with new positive D7
reactions. Literature reports on the prevalence of rubbers showing
new positive reactions at additional (late) patch test readings are
scarce. A study by Madsen et al evaluated a second patch test reading
on D6/D7 in patients who were tested with at least TRUE Test panels
1 and 2. Mercaptobenzothiazole and carba mix (together with paraben
mix) were the only allergens that did not show new positive reactions
at an additional reading, which is in agreement with our findings.7
4.1 | Associated factors
In general, contact allergies may be associated with several patient
characteristics. These include sex, age, and occupational dermati-
tis.22-30 Women tend to have a higher prevalence of contact allergies
than men.26 Furthermore, several studies have evaluated the effect of
age on the elicitation of contact allergy. Kwangsuksith et al reported a
decrease in reactivity upon primary exposure to new antigens in older
individuals, owing to senescence of the immune system.26 In our
study, sex was not significantly associated with a higher prevalence of
new positive reactions on D7. A study by Madsen et al reported sig-
nificantly more new positive reactions in women and in patients aged
>40 years.7 In the current study, an age of 18 to 30 years were signifi-
cantly less associated with new positive D7 reactions than an age of
≥61 years. However, allergens could be a confounding factor. The
allergen with the highest proportion of new D7 reactions was neomy-
cin sulfate. The use of neomycin sulfate in topicals in The Netherlands
was reduced years ago. Consequently, it was mainly the elderly who
were exposed, which could explain the lower proportion of new posi-
tive reactions in the age group 18 to 30 years. Logistic regression
analysis was controlled for age and sex. Nevertheless, we found a sig-
nificant association for age in all subgroups of allergens analysed.
Thus, the effect of age can be only partly moderated by the exposure
to allergens. For patients suffering from occupational dermatitis, it
could be hypothesized that sensitization occurs earlier because of a
high probability of impaired barrier function of the skin resulting from
concomitant exposure to irritants, allowing for more rapid penetration
of the contact allergen.23,30 In the current analysis, no differences
were observed for the presence of occupational dermatitis between
patients with new positive D7 reactions and patients with positive D3
reactions. Concerning the overall prevalence of contact allergy in
atopic vs non-atopic dermatitis patients, Johansen et al concluded
that there were no significant differences.31 In the current analysis,
the prevalence of new positive D7 reactions was also comparable
between atopic and non-atopic dermatitis patients.
4.2 | Strength and limitations
The added value of a D7 reading has been underscored by previous
studies, but these investigations have mostly been performed on small
populations, whereas the current study was performed on a large
sample. A novel aspect was the investigation of patient characteristics
in relation to late positive reactions. One limitation is the retrospec-
tive nature of the study. Furthermore, it is challenging to compare
publications about new (delayed) positive patch test reactions at addi-
tional (late) patch test readings. Patch test materials and concentra-
tions, vehicles, techniques and patch test interpretation differ
between studies. Furthermore, variations in terminology and day of
the additional patch test reading (D5-D9) do not always match in the
compared studies.
5 | CONCLUSION
The results of the present analysis support the importance of an addi-
tional late patch test reading on D7. Especially for topicals and corti-
costeroids, the share of new D7 reactions is high. Our results show
that, in patients tested with True Test panel 1 and 2 and additional
allergens, 13.5% of positive reactions are missed if no D7 reading is
performed. Therefore, it is recommended to perform a D7 patch test
reading to detect new, clinically relevant positive patch test reactions.
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